跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Xarelto - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Xarelto
Approved
STANDARD
Xarelto
Bayer Bitterfeld GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
50de0be93a9ceb87
Company
Bayer Bitterfeld GmbH
Type
Standard
Approval Details
Approval Id
50de0be93a9ceb87
Drug Approval Philippines Name
Xarelto
Product Name
Xarelto
Registration Number
DR-XY49359
Brand Name
Xarelto
Generic Name
Rivaroxaban
Dosage Form
Film-Coated Tablet
Dosage Strength
2.5 mg
Manufacturer
Bayer Bitterfeld GmbH
Importer
Bayer Philippines, Inc.
Distributor
Bayer Philippines, Inc.
Company Detail Path
/organization/bayer-bitterfeld-gmbh
Issuance Date
26 March 2025
Expiry Date
25 March 2030
Pharmacologic Category
Antithrombotic (Direct Factor Xa Inhibitor)
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
50de0be93a9ceb87
Type
Standard
Back to Philippines FDA Approvals